Table of Content

1 Measle Vaccine Market Overview
1.1 Product Overview and Scope of Measle Vaccine
1.2 Measle Vaccine Segment by Type
1.2.1 Global Measle Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.3 Measle Vaccine Segment by Application
1.3.1 Global Measle Vaccine Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Measle Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measle Vaccine Revenue 2018-2034
1.4.2 Global Measle Vaccine Sales 2018-2034
1.4.3 Global Measle Vaccine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Measle Vaccine Market Competition by Manufacturers
2.1 Global Measle Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Measle Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Measle Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Measle Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Measle Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measle Vaccine, Product Type & Application
2.7 Measle Vaccine Market Competitive Situation and Trends
2.7.1 Measle Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Measle Vaccine Players Market Share by Revenue
2.7.3 Global Measle Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measle Vaccine Retrospective Market Scenario by Region
3.1 Global Measle Vaccine Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Measle Vaccine Global Measle Vaccine Sales by Region: 2018-2034
3.2.1 Global Measle Vaccine Sales by Region: 2018-2024
3.2.2 Global Measle Vaccine Sales by Region: 2024-2034
3.3 Global Measle Vaccine Global Measle Vaccine Revenue by Region: 2018-2034
3.3.1 Global Measle Vaccine Revenue by Region: 2018-2024
3.3.2 Global Measle Vaccine Revenue by Region: 2024-2034
3.4 North America Measle Vaccine Market Facts & Figures by Country
3.4.1 North America Measle Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Measle Vaccine Sales by Country (2018-2034)
3.4.3 North America Measle Vaccine Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Measle Vaccine Market Facts & Figures by Country
3.5.1 Europe Measle Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Measle Vaccine Sales by Country (2018-2034)
3.5.3 Europe Measle Vaccine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measle Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Measle Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Measle Vaccine Sales by Country (2018-2034)
3.6.3 Asia Pacific Measle Vaccine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Measle Vaccine Market Facts & Figures by Country
3.7.1 Latin America Measle Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Measle Vaccine Sales by Country (2018-2034)
3.7.3 Latin America Measle Vaccine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measle Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Measle Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Measle Vaccine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Measle Vaccine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Measle Vaccine Sales by Type (2018-2034)
4.1.1 Global Measle Vaccine Sales by Type (2018-2024)
4.1.2 Global Measle Vaccine Sales by Type (2024-2034)
4.1.3 Global Measle Vaccine Sales Market Share by Type (2018-2034)
4.2 Global Measle Vaccine Revenue by Type (2018-2034)
4.2.1 Global Measle Vaccine Revenue by Type (2018-2024)
4.2.2 Global Measle Vaccine Revenue by Type (2024-2034)
4.2.3 Global Measle Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Measle Vaccine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Measle Vaccine Sales by Application (2018-2034)
5.1.1 Global Measle Vaccine Sales by Application (2018-2024)
5.1.2 Global Measle Vaccine Sales by Application (2024-2034)
5.1.3 Global Measle Vaccine Sales Market Share by Application (2018-2034)
5.2 Global Measle Vaccine Revenue by Application (2018-2034)
5.2.1 Global Measle Vaccine Revenue by Application (2018-2024)
5.2.2 Global Measle Vaccine Revenue by Application (2024-2034)
5.2.3 Global Measle Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Measle Vaccine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Measle Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck Measle Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Biovac
6.2.1 Biovac Corporation Information
6.2.2 Biovac Description and Business Overview
6.2.3 Biovac Measle Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Biovac Measle Vaccine Product Portfolio
6.2.5 Biovac Recent Developments/Updates
6.3 McKesson Medical
6.3.1 McKesson Medical Corporation Information
6.3.2 McKesson Medical Description and Business Overview
6.3.3 McKesson Medical Measle Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 McKesson Medical Measle Vaccine Product Portfolio
6.3.5 McKesson Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measle Vaccine Industry Chain Analysis
7.2 Measle Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measle Vaccine Production Mode & Process
7.4 Measle Vaccine Sales and Marketing
7.4.1 Measle Vaccine Sales Channels
7.4.2 Measle Vaccine Distributors
7.5 Measle Vaccine Customers
8 Measle Vaccine Market Dynamics
8.1 Measle Vaccine Industry Trends
8.2 Measle Vaccine Market Drivers
8.3 Measle Vaccine Market Challenges
8.4 Measle Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Measle Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Measle Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Measle Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Measle Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Measle Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Measle Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Measle Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Measle Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Measle Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Measle Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Measle Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Measle Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Measle Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measle Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Measle Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Measle Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Measle Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Measle Vaccine Sales by Region (2024-2034) & (K Units)
Table 20. Global Measle Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Measle Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Measle Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Measle Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Measle Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Measle Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Measle Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Measle Vaccine Sales by Country (2024-2034) & (K Units)
Table 28. North America Measle Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Measle Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Measle Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Measle Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Measle Vaccine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Measle Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Measle Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Measle Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Measle Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Measle Vaccine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Measle Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Measle Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Measle Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Measle Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Measle Vaccine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Measle Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Measle Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Measle Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Measle Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Measle Vaccine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Measle Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Measle Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Measle Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Measle Vaccine Sales (K Units) by Type (2024-2034)
Table 52. Global Measle Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Measle Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Measle Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Measle Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Measle Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Measle Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Measle Vaccine Price (USD/Unit) by Type (2018-2024)
Table 59. Global Measle Vaccine Price (USD/Unit) by Type (2024-2034)
Table 60. Global Measle Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Measle Vaccine Sales (K Units) by Application (2024-2034)
Table 62. Global Measle Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Measle Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Measle Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Measle Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Measle Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Measle Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Measle Vaccine Price (USD/Unit) by Application (2018-2024)
Table 69. Global Measle Vaccine Price (USD/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Merck Measle Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Biovac Corporation Information
Table 76. Biovac Description and Business Overview
Table 77. Biovac Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Biovac Measle Vaccine Product
Table 79. Biovac Recent Developments/Updates
Table 80. McKesson Medical Corporation Information
Table 81. McKesson Medical Description and Business Overview
Table 82. McKesson Medical Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. McKesson Medical Measle Vaccine Product
Table 84. McKesson Medical Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Measle Vaccine Distributors List
Table 88. Measle Vaccine Customers List
Table 89. Measle Vaccine Market Trends
Table 90. Measle Vaccine Market Drivers
Table 91. Measle Vaccine Market Challenges
Table 92. Measle Vaccine Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Measle Vaccine
Figure 2. Global Measle Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Measle Vaccine Market Share by Type in 2022 & 2034
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Attenuated Vaccine Product Picture
Figure 6. Global Measle Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Measle Vaccine Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Global Measle Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Measle Vaccine Market Size (2018-2034) & (US$ Million)
Figure 13. Global Measle Vaccine Sales (2018-2034) & (K Units)
Figure 14. Global Measle Vaccine Average Price (USD/Unit) & (2018-2034)
Figure 15. Measle Vaccine Report Years Considered
Figure 16. Measle Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global Measle Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Measle Vaccine Players: Market Share by Revenue in 2022
Figure 19. Measle Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Measle Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America Measle Vaccine Sales Market Share by Country (2018-2034)
Figure 22. North America Measle Vaccine Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Measle Vaccine Sales Market Share by Country (2018-2034)
Figure 26. Europe Measle Vaccine Revenue Market Share by Country (2018-2034)
Figure 27. Germany Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Measle Vaccine Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Measle Vaccine Revenue Market Share by Region (2018-2034)
Figure 34. China Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Philippines Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Measle Vaccine Sales Market Share by Country (2018-2034)
Figure 45. Latin America Measle Vaccine Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Measle Vaccine Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Measle Vaccine Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. U.A.E Measle Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Measle Vaccine by Type (2018-2034)
Figure 55. Global Revenue Market Share of Measle Vaccine by Type (2018-2034)
Figure 56. Global Measle Vaccine Price (USD/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Measle Vaccine by Application (2018-2034)
Figure 58. Global Revenue Market Share of Measle Vaccine by Application (2018-2034)
Figure 59. Global Measle Vaccine Price (USD/Unit) by Application (2018-2034)
Figure 60. Measle Vaccine Value Chain
Figure 61. Measle Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed